Therapeutic potential for KCC2-targeted neurological diseases

Tomita, K; Kuwahara, Y; Igarashi, K; Kitanaka, J; Kitanaka, N; Takashi, Y; Tanaka, KI; Roudkenar, MH; Roushandeh, AM; Kurimasa, A; Nishitani, Y; Sato, T

Tomita, K; Sato, T (通讯作者)，Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Appl Pharmacol, Kagoshima 8908544, Japan.

JAPANESE DENTAL SCIENCE REVIEW, 2023; 59 (): 431

Abstract

Patients with neurological diseases, such as schizophrenia, tend to show low K+ -Cl- co-transporter 2 (KCC2) levels in the brain. The cause of these d......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索